Beam Therapeutics, Inc. (BEAM)
27.72
-0.10
(-0.36%)
USD |
NASDAQ |
Dec 31, 16:00
27.71
-0.01
(-0.04%)
Pre-Market: 20:00
Beam Therapeutics Cash from Investing (Quarterly): 65.66M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -6.163M |
| Intellia Therapeutics, Inc. | -0.741M |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Amicus Therapeutics, Inc. | -1.299M |
| Repligen Corp. | -7.783M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -81.48M |
| Cash from Financing (Quarterly) | 1.675M |
| Free Cash Flow | -352.36M |
| Free Cash Flow Per Share (Quarterly) | -0.8432 |
| Free Cash Flow to Equity (Quarterly) | -83.11M |
| Free Cash Flow to Firm (Quarterly) | -86.49M |
| Free Cash Flow Yield | -13.55% |